Skip to main content
Print Save

Carbinoxamine / dextromethorphan / phenylephrine Pregnancy and Breastfeeding Warnings

Carbinoxamine / dextromethorphan / phenylephrine is also known as: DMax, DMax Pediatric, DMax Pediatric Drops, DMax Syrup, Dacex-A, TriTuss-A Drops, Trituss-A, X-Hist DM, XiraHistDM

Carbinoxamine / dextromethorphan / phenylephrine Pregnancy Warnings

Carbinoxamine/dextromethorphan/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbinoxamine/dextromethorphan/phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Carbinoxamine / dextromethorphan / phenylephrine Breastfeeding Warnings

There are no data on the excretion of carbinoxamine/dextromethorphan/phenylephrine into human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Trituss-A Drops (carbinoxamine/dextromethorphan/phenylephrine)." Everett Laboratories Inc (2004):
  2. "Product Information. Dacex-A (carbinoxamine/dextromethorphan/phenylephrine)." Cypress Pharmaceutical Inc (2005):

References for breastfeeding information

  1. "Product Information. Trituss-A Drops (carbinoxamine/dextromethorphan/phenylephrine)." Everett Laboratories Inc (2004):
  2. "Product Information. Dacex-A (carbinoxamine/dextromethorphan/phenylephrine)." Cypress Pharmaceutical Inc (2005):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer